Canada Pension Plan Investment Board
CRVS icon

Canada Pension Plan Investment Board’s Corvus Pharmaceuticals CRVS Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,426
Closed -$10K – 1295
2019
Q1 		$10K Buy
+2,426
New +$10.2K ﹤0.01% 1417

Other funds holding CRVS

OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $443M AUM 49.46% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Canada Pension Plan Investment Board's CRVS Position: Q2 2019 in Review

Canada Pension Plan Investment Board sold out of Corvus Pharmaceuticals (CRVS) in Q2 2019, closing a stake of 2,426 shares — an estimated $10K sold.

Canada Pension Plan Investment Board first reported a position in CRVS in Q1 2019 and held it in 1 quarter. The position peaked at $10K in Q1 2019. 45 funds tracked by Wall St. Rank hold CRVS as of Q2 2019.

  • Canada Pension Plan Investment Board reported no remaining Corvus Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 2,426 Corvus Pharmaceuticals shares in Q2 2019, an estimated $10K.
  • Canada Pension Plan Investment Board first reported a position in Corvus Pharmaceuticals in Q1 2019 and held it in 1 quarter.
  • Canada Pension Plan Investment Board's Corvus Pharmaceuticals position peaked at $10K in Q1 2019.
  • 45 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2019.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2019, filed 12 Aug 2019.